Literature DB >> 6271678

Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa.

P A Sokol, B H Iglewski, T A Hager, J C Sadoff, A S Cross, A McManus, B F Farber, W J Iglewski.   

Abstract

Exoenzyme S differs from toxin A and diphtheria toxin in that it does not adenosine diphosphate (ADP)-ribosylate elongation factor-2, but rather catalyzes the transfer of the ADP-ribose moiety of nicotinamide adenine dinucleotide to a number of different proteins in extracts of eucaryotic cells. Polyoma-transformed BHK-21 cells were isolated which were resistant to diphtheria toxin and toxin A. Extracts from these cells are ADP-ribosylated by exoenzyme S but not toxin A or diphtheria toxin, providing an assay which distinguishes between S and A activities. A total of 124 clinical isolates of P. aeruginosa were analyzed for production of toxin A and exoenzyme S. Exoenzyme S production was detected in 38% of the strains, whereas 80% of the strains produced toxin A.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271678      PMCID: PMC350835          DOI: 10.1128/iai.34.1.147-153.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  29 in total

1.  Differential chemical protection of mammalian cells from the exotoxins of Corynebacterium diphtheriae and Pseudomonas aeruginosa.

Authors:  J L Middlebrook; R B Dorland
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Biology of Pseudomonas aeruginosa.

Authors:  P V Lui
Journal:  Hosp Pract       Date:  1976-01

4.  The role of exotoxins in the pathogenesis of Pseudomonas aeruginosa infections.

Authors:  L S Young
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

5.  Selection and characterization of cells resistant to diphtheria toxin and pseudomonas exotoxin A: presumptive translational mutants.

Authors:  T J Moehring; J M Moehring
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

6.  Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa.

Authors:  D W Chung; R J Collier
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

7.  Structure-activity relationships of an exotoxin of Pseudomonas aeruginosa.

Authors:  M L Vasil; D Kabat; B H Iglewski
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

8.  Exotoxin production by clinical isolates of pseudomonas aeruginosa.

Authors:  M Pollack; N S Taylor; L T Callahan
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

9.  Incidence of exotoxin production by Pseudomonas species.

Authors:  M J Bjorn; M L Vasil; J C Sadoff; B H Iglewski
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtheriae: differential cytotoxicity.

Authors:  J L Middlebrook; R B Dorland
Journal:  Can J Microbiol       Date:  1977-02       Impact factor: 2.419

View more
  10 in total

1.  Endogenous ADP-ribosylation of elongation factor 2 in polyoma virus-transformed baby hamster kidney cells.

Authors:  J L Fendrick; W J Iglewski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections.

Authors:  P Visca; F Chiarini; A Mansi; C Vetriani; L Serino; N Orsi
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

3.  Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa.

Authors:  D E Woods; P A Sokol
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

4.  Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections.

Authors:  T I Nicas; D W Frank; P Stenzel; J D Lile; B H Iglewski
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

5.  Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection.

Authors:  Jeevan Jyot; Viviane Balloy; Gregory Jouvion; Amrisha Verma; Lhousseine Touqui; Michel Huerre; Michel Chignard; Reuben Ramphal
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

6.  Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.

Authors:  T I Nicas; B H Iglewski
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

7.  [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].

Authors:  U Winkler; J Wingender; K E Jäger
Journal:  Klin Wochenschr       Date:  1985-06-03

8.  Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.

Authors:  D E Woods; M S Schaffer; H R Rabin; G D Campbell; P A Sokol
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 11.677

Review 9.  Bacterial toxins: cellular mechanisms of action.

Authors:  J L Middlebrook; R B Dorland
Journal:  Microbiol Rev       Date:  1984-09

Review 10.  The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response.

Authors:  Teiji Sawa
Journal:  J Intensive Care       Date:  2014-02-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.